Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity.
Pfefferlé M, Dubach IL, Buzzi RM, Dürst E, Schulthess-Lutz N, Baselgia L, Hansen K, Imhof L, Koernig S, Le Roy D, Roger T, Humar R, Schaer DJ, Vallelian F.
Pfefferlé M, et al. Among authors: vallelian f.
J Immunother Cancer. 2023 Jan;11(1):e005718. doi: 10.1136/jitc-2022-005718.
J Immunother Cancer. 2023.
PMID: 36593065
Free PMC article.